Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead
New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Bit Origin announces 1-for-60 reverse stock split to maintain Nasdaq listing
Post Content
REMSleep receives FDA clearance for expanded DeltaWave use
Post Content
Goldman Sachs Q4 2025 slides: Strong EPS growth despite revenue miss
Post Content
US imposes sanctions on Iran over crackdown on protesters
Post Content
Alphatec Holdings, Inc. (ATEC) Shares Preliminary 2025 Results and 2026 Outlook
Post Content
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)
Post Content
Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why
Post Content
Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026
Post Content
Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside
Post Content